AQST Stock Analysis: Buy, Sell, or Hold?
AQST - Aquestive Therapeutics, Inc. Common Stock
$3.99
-0.11 (-2.80%)
▼
5d:
+22.99%
30d:
-36.04%
90d:
-38.6%
BUY
HIGH Confidence
Analysis Updated: Feb 4, 2026 12:00 AM ET
Earnings: Mar 04, 2026
27d
Get Alerted When AQST Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
27 traders called AQST this week
85% bullish • 6 bearish
85% bullish • 6 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: AQST shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: AQST shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: AQST is currently trading at $3.98, which is considered fair relative to its 30-day fair value range of $3.01 to $5.70.
Technical Outlook: Technically, AQST is in a strong uptrend. Immediate support is located at $2.93, while resistance sits at $4.39.
Market Sentiment: AQST has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.75 (+113.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, AQST is in a strong uptrend. Immediate support is located at $2.93, while resistance sits at $4.39.
Market Sentiment: AQST has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.75 (+113.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$3.01 -
$5.70
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.8%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 113.4% below Wall St target ($8.75)
Fair Price Analysis
30-Day Fair Range
$3.01 -
$5.70
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$2.93
Resistance Level
$4.39
Current Trend
Strong Uptrend
Technical data as of
Feb 4, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-9.21
Wall Street Target
$8.75
(+113.4%)
Revenue Growth (YoY)
-5.4%
Profit Margin
-158.9%
Last updated: February 04, 2026 2:28 PM ET
Data refreshes hourly during market hours. Next update: 3:28 PM
Data refreshes hourly during market hours. Next update: 3:28 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AQST showing a specific setup today?
Insider Activity (6 Months)
0
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
Carl N Kraus
SELL
20272 shares
2025-10-15
Cassie Jung
SELL
67575 shares
2025-10-15
Peter E Boyd
SELL
10000 shares
2025-10-15
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$180 | 58 HOLD |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$154 | 68 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$83 | 55 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$22 | 58 HOLD |
|
TEVA
Teva Pharma Industries L… |
STRONG BUY
11 analysts |
$37 | 59 HOLD |
